Psychedelic Brain Science

Psychedelic Brain Science

By Psychedelic Brain ScienceScience
Download on the App Store

Psychedelic Brain Science episodes

  • What is a Psychedelic? ft. Dr. Boris Heifets

    In this episode, Alaina discusses the evolving language about some of our favorite substances and how we got to the term psychedelic. In the first segment, she highlights some historical names for psychedelic substances in western medicine. In the second segment, she is joined by Stanford anesthesiologist and psychedelic researcher Dr. Boris Heifets to discuss how the scientific field classifies compounds as psychedelic and how to make sense of the psychedelic experience.


    For more on Dr. Heifets research:

    https://heifetslab.stanford.edu/publications/


    For more on the history and references discussed in the introduction:

    https://pubmed.ncbi.nlm.nih.gov/14761703/

    https://www.sciencedirect.com/science/article/pii/S0278584606000364

    https://psychiatryonline.org/doi/abs/10.1176/ajp.108.8.572

    https://academic.oup.com/ijnp/article/16/10/2165/652314?login=true

    https://marijuana-uses.com/mr-x/

    https://content.ucpress.edu/title/9780520285422/9780520285422_chapter1.pdf

    Content only reflects opinions of the authors and does not reflect the opinion of others or author affiliations.

    1 hr 4 min
  • Special Episode: Charting a Path Forward ft. Dr. Gill Bedi & Dr. Neşe Devenot

    This special episode includes presentations from a recent workshop, where Dr. Alaina Jaster, Dr. Neşe Devenot of Johns Hopkins and Dr. Gill Bedi of University of Melbourne presented their expertise and perspectives on how the psychedelic research field can move forward from the recent FDA rejection of MDMA-AT.

    Dr. Jaster's presentation sets the tone by going over recent events, followed by how researchers can be involved in promoting evidence-based regulatory and policy decisions.

    Dr. Devenot's presentation focused on what it means to be a psychedelic bioethicist and how the recent events have conflated constructive criticism with attacks, followed by a call to be better about having these discussions.

    Dr. Bedi's presentation discussed how scientists studying MDMA and other psychedelics can better their study design and use methodology that is evidence-based and thorough.

    These taken together, provided the framework for how to move forward in the field and prompted a discussion by members in the crowd (of which was not recorded to protect those participating).


    For more information and to see some of the slides, you can go to psychedeliccbrainscience.com

    43 min
  • Seeing Through the Smoke ft. Dr. Peter Grinspoon

    Alaina is joined by physician, author, activist and educator Dr. Peter Grinspoon to discuss the use of psychedelics and cannabis in recovery, the stigma associated with drug use and the idea of "california sober."

    Have questions or want to read his book? Check out Dr. Grinspoon's website https://www.petergrinspoon.com/


    55 min
  • Psychedelic Circuits: The Amygdala ft. Dr. Devin Effinger

    This episode is the last of the Psychedelic Circuits mini-series! Today, Alaina gives a brief overview on circuits involved in stress responses. Then Dr. Devin Effinger deep dives into his work with the amygdala, paraventricular nucleus and how these regions send signals to relay important information about threat, stress and more. This circuit goes beyond just anxiety disorders and can also be implicated in substance use disorders.


    For publications of Dr. Effinger related to our discussion:

    https://drive.google.com/drive/folders/1kg0tH2iRxDbR6UyaVtg9DGHOf78GXwG_?usp=drive_link

    54 min
  • Special Episode: Tales from the DEA Hearing ft. Jack Gorsline

    Welcome to a super extra special episode of Psychedelic Brain Science! Dr. Jaster has finally settled back into real life after spending a week at DEA HQ fighting with Students for Sensible Drug Policy and many other scientists to keep DOI and DOC legal. She's joined today by psychedelic journalist Jack Gorsline, who was embedded with the team. They go through each day and give highlights and takeaways from the experience.


    For more of Jack Gorsline:

    https://doubleblindmag.com/author/jack-gorsline/

    https://filtermag.org/author/jack-gorsline/

    https://psychedelicalpha.com/?s=jack+gorsline


    Coverage by Hamilton Morris:

    https://www.patreon.com/HamiltonMorris

    For podcast episodes on this topic:

    https://www.psychedelicbrainscience.com/podcast/episode/1c16abd2/sensible-drug-policy-in-the-psychedelic-era-part-2-ft-special-guests

    https://www.psychedelicbrainscience.com/podcast/episode/1b884a6b/sensible-drug-policy-in-the-psychedelic-era-ft-special-guests

    Episode with Tanner Anderson:

    https://www.psychedelicbrainscience.com/podcast/episode/27ff1c32/psychedelic-circuits-the-claustrum-ft-tanner-anderson

    Episode with Dr. Cameron

    https://www.psychedelicbrainscience.com/podcast/episode/1f74c1a7/plasticity-and-psychoplastogens-ft-lindsay-cameron

    Episode with Dr. de la Fuente

    https://www.psychedelicbrainscience.com/podcast/episode/1cdc3577/wtf-is-a-head-twitch-ft-dr-mario-de-la-fuente

    Episodes with Dr. Elder

    https://www.psychedelicbrainscience.com/podcast/episode/251caf98/special-episode-the-state-of-psychoactiveentheogenic-plants-and-fungi

    https://www.psychedelicbrainscience.com/podcast/episode/2ea213a9/struture-function-part-one-ft-harrison-elder

    https://www.psychedelicbrainscience.com/podcast/episode/1fb85762/structure-function-part-two-ft-harrison-elder

    Episode with Dr. Charles Nichols

    https://www.psychedelicbrainscience.com/podcast/episode/2839565b/are-psychedelics-anti-inflammatory-ft-dr-charles-nichols

    Episode with Dr. Ramos

    https://www.psychedelicbrainscience.com/podcast/episode/23032876/psychedelic-circuits-the-spinal-cord-ft-dr-raul-ramos


    1 hr 43 min
  • Psychedelic Circuits: The Spinal Cord ft. Dr. Raul Ramos

    This episode is the second installment of the mini-series focused on brain circuits outside of the typical frontal cortex conversation. Today, we hear from Alaina on the basics of pain and touch perception, as well as how our nerves send information to our brains. Alaina is then joined by Dr. Raul Ramos of UC Berkeley, an expert on studying sensory modalities who is now focusing their work on phenethylamine psychedelics, including DOI. This episode includes a special guest from a previous episode, talk about the clitoris, and the Grateful Dead.


    Resources discussed in this episode including papers, diagrams, and a very cool video can be found at this link: https://drive.google.com/drive/folders/12jTUQnRxCCVZ93nsysNMT0ANF2fTQ8Ug?usp=drive_link


    54 min
  • Psychedelic Circuits: The Claustrum ft. Tanner Anderson

    This episode is the first of three in a mini-series focused on brain circuits outside of the typical conversations. Today, we hear from Alaina on the basics of how neurons talk to each other and a refresher on serotonin signaling. Alaina is then joined by special guest Tanner Anderson, a PhD candidate at University of Kentucky and soon to be postdoc at Yale. Tanner will discuss his recently published findings related to cortical excitability and this fun brain region called the claustrum.


    Find his JUST PUBLISHED paper here: https://drive.google.com/file/d/1HAQcUFAuP5igAoa7FykWgT8tZXvuYbnK/view?usp=sharing

    50 min
  • Sensible Drug Policy in the Psychedelic Era Part 2 ft. Dr. Elijah Ullman, Brett Phelps & Robert Rush

    Welcome to season 4. In this two part episode, Alaina talks about the ongoing petition against the DEA's proposed rule to schedule DOI and DOC. In the first half of this episode, Alaina is joined by Elijah Z. Ullman, of the SSDP Science Policy Committee. They discuss the background and specific reasons why DOI and DOC should not be scheduled. In the second half of the podcast, Alaina is joined by Brett Phelps and Robert Rush, the legal counsel representing two of the three parties involved in the DEA case.


    For more information on SSDP visit: https://ssdp.org/

    For more information on our lawyers:

    https://rrushlaw.com/about/

    https://brettphelpslaw.com/

    Suggested reading on the topic:

    https://www.marijuanamoment.net/deas-move-to-ban-two-psychedelics-is-challenged-as-a-disservice-to-science-in-legal-filing-from-student-group/

    https://filtermag.org/block-dea-psychedelics-ban/

    https://www.aspet.org/docs/default-source/advocacy-files/aspet-dea-doi-and-doc-comments-1-12-2024.pdf?sfvrsn=62e172d3_0

    https://www.nature.com/articles/nrn3530


    Content only reflects opinions of the authors and does not reflect the opinion of others or author affiliations.

    Support this podcast: 

    https://podcasters.spotify.com/pod/show/psychedelicbrainscience/support

    1 hr 15 min
  • Special Episode: The State of Psychoactive/Entheogenic Plants and Fungi

    Join us for this special episode featuring discussion from the Richmond, VA annual Mushroom Mania festival presented by the RVA Moon Market.


    Alaina is joined by fellow panelists:

    Will E. Nelson, Co-founder of Decriminalize Nature RVA

    Isa Boliver, South American Medicine Woman

    Dr. Harrison Elder, postdoctoral researcher at Johns Hopkins researching cannabis and psychedelics

    Alistaire McKemy MSW, licensed clinical social worker

    focused on complex and/or developmental trauma and harm reduction
    Eric Postow Esq. Managing Partner and Chief Strategy Officer at Holon Law Partners

    1 hr 12 min

About Psychedelic Brain Science

From the publisher's feed

Psychedelic Brain Science is a multimedia approach dedicated to bringing scientific, psychological, anthropological, and cultural information as it relates to psychedelics. Join scientists Alaina M. Jaster, PhD and Zarmeen Zahid, PhD as they work to provide better understanding of the ongoing research about psychedelics.